SCHEMBL7985359

SCHEMBL7985359

O=c1[nH]c(-c2cccc(Cl)c2)nc2ncn(Cc3cccc(F)c3)c12

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.45
GRIN2B Q13224 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 2/20 0.45
KMT2A Q03164 1/20 0.44
POLB P06746 1/20 0.43
THRB P10828 1/20 0.43
HPGD P15428 1/20 0.43
GLA P06280 1/20 0.42
HTT P42858 1/20 0.42
UBE2N P61088 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ACP1 P24666 2/20 0.42
YTHDC1 Q96MU7 1/20 0.40
MAPK1 P28482 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987307 0.96 GRIN1 (0.46) GRIN1GRIN2BSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7991667 0.93 ALDH1A1 (0.46) GRIN1GRIN2BSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7973624 0.93 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1KMT2AHPGDGLA
SCHEMBL7988776 0.92 SMN1; SMN2 (0.44) GRIN1GRIN2BSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7974010 0.91 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDGLA
SCHEMBL7987251 0.90 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDACP1
SCHEMBL7985787 0.90 SMN1; SMN2 (0.50) GRIN1GRIN2BSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7988814 0.89 MAPK1 (0.46) GRIN1GRIN2BSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7985297 0.89 ALDH1A1 (0.43) GRIN1GRIN2BSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7991634 0.88 ALDH1A1 (0.45) GRIN1GRIN2BSMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed